SynthesisClinical and translational science2022

Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro.

Christian Hammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.